Development of the First Clinical Classification of Medications Used during Lactation and the Evaluation of 1380 Drugs (original) (raw)

The infant may be recognized as the unintended recipient of drugs administered to the lactating mother. Our objective is to create a practical classification and to provide health care practitioners with the most updated data on drug use during lactation. Data on more than one thousand drugs have been collected from published medical literature. Data include drug excretion into breast milk, possible adverse effects on the infant, as well as the compatibility of the drug with breast-feeding. Each drug is represented by two letters and symbols to identify the aforementioned information. The first letter indicates compatibility with breast-feeding, which is denoted by C (Compatible), I (Incompatible), or U (Unknown). The second letter indicates Clinical Research and Regulatory Affairs Downloaded from informahealthcare.com by South College on 02/27/13